AMGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.22 BRL | -1.87% |
|
-1.31% | +14.55% |
| 14/06 | Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto | DJ |
| 14/06 | Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | -1.87% | -1.31% | +14.55% | +46.49% | +136.49% | 160B | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- AMGN Stock
- AMGN34 Stock
- Charts Amgen Inc.
- Comparison Chart
